Polyplastics Develops New “DURACON(R) POM PM Series” for Medical/Healthcare Industry
TOKYO, Jan. 22, 2019 /PRNewswi…
Bridge Biotherapeutics Announces FDA Orphan Drug Designation for BBT-877 in Idiopathic Pulmonary Fibrosis (IPF)
The U.S. FDA grants an orphan …
BookDoc partners Special Olympics Asia Pacific to encourage active lifestyles among people with intellectual disabilities
SINGAPORE, Jan. 21, 2019 /PRNe…
Johnson & Johnson Completes Acquisition of Ci:z Holdings Co., Ltd.
Acquisition Expands J&J…
Young Living Essential Oils Welcomes Wayne Moorehead as Executive Vice President of Marketing
Young Living’s New EVP o…
Cell Therapy Market to Grow Beyond Oncology As Big Pharma Expands Investments
Collaborative business approac…
